Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v3.23.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Revenues $ 36,664 $ 31,007
Cost of goods sold 6,709 5,546
Gross profit 29,955 25,461
Costs and expenses:    
Sales and marketing 21,618 20,888
Research and development 6,679 6,275
General and administrative 8,999 9,618
Total costs and expenses 37,296 36,781
Loss from operations (7,341) (11,320)
Other income (expense):    
Investment income (loss) 549 (46)
Interest expense (16) (354)
Change in fair value of derivatives (185) 252
Other expense (81) (7)
Total other income (expense), net 267 (155)
Net loss $ (7,074) $ (11,475)
Weighted average common shares outstanding - basic (in shares) 42,571,021 41,804,330
Weighted average common shares outstanding - diluted (in shares) 42,571,021 41,804,330
Loss per common share - basic (in USD per share) $ (0.17) $ (0.27)
Loss per common share - diluted (in USD per share) $ (0.17) $ (0.27)